3,003
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, characterization and anti-cancer activity of Pluronic F68–curcumin conjugate micelles

, , , , , & show all
Pages 2587-2595 | Received 26 Feb 2015, Accepted 01 Apr 2015, Published online: 12 Jun 2015

References

  • Agrawal DK, Mishra PK. (2010). Curcumin and its analogues: potential anticancer agents. Med Res Rev 30:818–60
  • Anand P, Kunnumakkara AB, Newman RA, et al. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18
  • Anitha A, Deepa N, Chennazhi KP, et al. (2014). Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment. BBA Gen Subjects 1840:2730–43
  • Arunraj TR, Rejinold NS, Mangalathillam S, et al. (2014). Synthesis, characterization and biological activities of curcumin nanospheres. J Biomed Nanotechnol 10:238–50
  • Batrakova EV, Kabanov AV. (2008). Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130:98–106
  • Basniwal RK, Buttar HS, Jain VK, Jain N (2011). Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem 59:2056–61
  • Bildstein L, Dubernet C, Couvreur P. (2011). Prodrug-based intracellular delivery of anticancer agents. Adv Drug Deliv Rev 63:3–23
  • Byagari K, Shanavas A, Rengan AK, et al. (2014). Biocompatible amphiphilic pentablock copolymeric nanoparticles for anti-cancer drug delivery. J Biomed Nanotechnol 10:109–19
  • Chen X, Zhou ZW, Xue CC, et al. (2007). Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood–brain barrier. Xenobiotica 37:635–78
  • Dey S, Sreenivasan K. (2014). Conjugation of curcumin onto alginate enhances aqueous solubility and stability of curcumin. Carbohyd Polym 99:499–507
  • Du Q, Hu B, An HM, et al. (2013). Synergistic anticancer effects of curcumin and resveratrol in Hepa1–6 hepatocellular carcinoma cells. Oncol Rep 29:1851–8
  • Ediriwickrema A, Saltzman WM. (2015). Nanotherapy for cancer: targeting and multifunctionality in the future of cancer therapies. ACS Biomater Sci Eng 1:64–78
  • Fang J, Nakamura H, Maeda H. (2011). The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–51
  • Guo QF, Li SL, Yang Y, et al. (2014). Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(l-lactide) grafted polyethylenimine cationic nanoparticles. J Biomed Nanotechnol 10:227–37
  • Gururaj AE, Belakavadi M, Venkatesh DA, et al. (2002). Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297:934–42
  • He YW, Wang HS, Zeng J, et al. (2013). Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells. Life Sci 93:509–15
  • Hong R, Wu YQ, Wu Y. (2014). Effect of curcumin in inducing apoptosis of MDA-MB-213 cells by activating endoplasmic reticulum stress. Zhongguo Zhong Yao Za Zhi 39:1495–8
  • Hu XL, Jing XB. (2009). Biodegradable amphiphilic polymer–drug conjugate micelles. Expert Opin Drug Deliv 6:1079–90
  • Huang YQ, Luo ZY. (2014). Preparation and characterizations of a novel copolymer based on an emulsion solvent evaporation method. Mater Technol 48:355–9
  • Ide H. (2012). Prostate cancer and curcumin: current application and future prospect. Int J Urol 19:SI59
  • Kabanov AV, Batrakova EV, Alakhov VY. (2002). Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82:189–212
  • Ke XY, Ng VWL, Gao SJ, et al. (2014). Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials 35:1096–108
  • Liu JB, Zeng FQ, Allen C. (2005). Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent. J Control Release 103:481–97
  • Ma WC, Zhang Q, Li H, et al. (2013). Development of intravenous lipid emulsion of alpha-asarone with significantly improved safety and enhanced efficacy. Int J Pharm 450:21–30
  • Mei L, Sun HF, Song CX. (2009). Local delivery of modified paclitaxel-loaded poly(epsilon-caprolactone)/Pluronic F68 nanoparticles for long-term inhibition of hyperplasia. J Pharm Sci 98:2040–50
  • Muthu MS, Kutty RV, Luo Z, et al. (2015). Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials 39:234–48
  • Pan MH, Huang TM, Lin JK. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486–94
  • Rejinold NS, Muthunarayanan M, Divyarani VV, et al. (2011). Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J Colloid Interface Sci 360:39–51
  • Safavy A, Raisch KP, Mantena S, et al. (2007). Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem 50:6284–8
  • Saha SC, Patel D, Rahman S, et al. (2013). Physicochemical characterization, solubilization, and stabilization of 9-nitrocamptothecin using pluronic block copolymers. J Pharm Sci 102:3653–65
  • Salem M, Rohani S, Gillies ER. (2014). Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery. RSC Adv 4:10815–29
  • Sandur SK, Ichikawa H, Pandey MK, et al. (2007). Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Rad Biol Med 43:568–80
  • Scarlett JL, Sheard PW, Hughes G, et al. (2000). Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475:267–72
  • Shah M, Agrawal Y. (2012). Ciprofloxacin hydrochloride-loaded glyceryl monostearate nanoparticle: factorial design of Lutrol F68 and Phospholipon 90G. J Microencapsul 29:331–43
  • Shishodia S, Chaturvedi MM, Aggarwal BB. (2007). Role of curcumin in cancer therapy. Curr Prob Cancer 31:243–305
  • Song YZ, Tian QJ, Huang ZJ, et al. (2014). Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system. Int J Nanomed 9:2307–17
  • Tang HD, Murphy CJ, Zhang B, et al. (2010). Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects. Nanomedicine (Lond) 5:855–65
  • Tian Y, Mao SR. (2012). Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs. Expert Opin Drug Deliv 9:687–700
  • Tonnesen HH, Masson M, Loftsson T. (2002). Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 244:127–35
  • Wang SP, Chen TK, Chen RE, et al. (2012). Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Int J Pharm 430:238–46
  • Wang L, Shen Y, Song R, et al. (2009). An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Mol Pharmacol 76:1238–45
  • Wang SP, Zhong ZF, Wan JB, et al. (2013). Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. Am J Chin Med 41:177–96
  • Wei XL, Han YR, Quan LH, et al. (2013). Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation. Eur J Pharm Sci 49:286–93
  • Yang KY, Lin LC, Tseng TY, et al. (2007). Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS. J Chromatogr B 853:183–9
  • Yang RL, Zhang SA, Kong DL, et al. (2012). Biodegradable polymer–curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm Res 29:3512–25
  • Yokoyama M, Kwon GS, Okano T, et al. (1992). Preparation of micelle-forming polymer drug conjugates. Bioconjugate Chem 3:295–301
  • Zhang J, Li Y, Fang X, et al. (2014a). TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy. Int J Pharm 476:185–98
  • Zhang JM, Li YB, Gao W, et al. (2014b). Andrographolide-loaded PLGA–PEG–PLGA micelles to improve its bioavailability and anticancer efficacy. Expert Opin Drug Deliv 11:1367–80
  • Zhang W, Bai W, Zhang W. (2014c). MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells. Clin Transl Oncol 16:708–13
  • Zhao X, Liu P. (2014). Reduction-responsive core-shell-corona micelles based on triblock copolymer: novel synthetic strategy, characterization, and application as tumor microenvironment-responsive drug delivery system. ACS Appl Mater Interfaces 7:166–174
  • Zheng DH, Li XL, Xu HE, et al. (2009). Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma. Acta Biochem Biophys Sin 41:578–87
  • Zhu W., Z. Song, P. Wei, et al. (2015). Y-shaped biotin-conjugated poly (ethylene glycol)-poly (epsilon-caprolactone) copolymer for the targeted delivery of curcumin. J Colloid Interface Sci 443:1–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.